Compare Medpace Holdings Inc (MEDP) vs Unity Software Inc (U) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Unity Software Inc — how do they compare? Medpace Holdings Inc trades at $611.57 (market cap $16.82B), while Unity Software Inc trades at $46.82 (market cap $20.20B). The key difference: Unity Software Inc is the larger of the two by market cap, and Medpace Holdings Inc is more actively traded (223,093 versus 15,432,191). Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Unity Software Inc for 50 Days on average.
| MEDP | U | |
|---|---|---|
Market Cap | $16.82B | $20.20B |
Volume | 223,093 | 15,432,191 |
Sector | Health | Technology |
52-Week High | $630.19 | $49.47 |
52-Week Low | $393.42 | $17.13 |
Typical Hold Time | 14 Days | 50 Days |
Enterprise Value | $16.44B | $20.08B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.
MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.
Unity Software (U) trades at $46.77, up 2.93% with strong bullish momentum. The stock shows improving fundamentals with revenue stabilizing around $1.8B and narrowing losses, though still unprofitable. Technical indicators signal bullish sentiment with the current price near resistance at $47. Recent news highlights Meta VR partnership driving positive sentiment, while analyst consensus remains strongly bullish with 82.76% buy ratings.
Unity presents a growth opportunity with strategic partnerships and improving financial trends, but faces significant execution risks. The company's high valuation multiples and persistent losses require careful monitoring of profitability progress. Near-term catalysts include VR market expansion and advertising platform growth, though competitive pressures and macroeconomic uncertainty remain key concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →
